The role of midbrain mTOR signaling in hyperactivity and impulsivity
About This Grant
Project Summary The mechanistic target of rapamycin (mTOR) is a serine/threonine-protein kinase that regulates cell growth, proliferation, and synaptic plasticity. Dysfunction in mTOR signaling has been implicated in several neurological disorders, including seizures, autism, and attention deficit hyperactivity disorder. However, there is limited understanding of how abnormal mTOR signaling in specific cell types leads to neuropsychiatric and behavioral disorders. The mTOR controls protein synthesis by sensing nutrient and energy levels. Midbrain dopamine neurons in the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) have large somata and widespread axonal arborizations rich in mitochondria. Their high energy demands make dopamine neurons highly sensitive to the status of mTOR signaling. To investigate the role of mTOR signaling in midbrain dopamine neurons, we generated dopamine neuron-specific mTOR conditional knockout (mTOR-cKO) mice by crossing mTOR-floxed mice with DAT-Cre mice. We made the serendipitous discovery that mTOR-cKO mice exhibited a pronounced increase in basal locomotor activity in an open field compared with that of wild-type mice, and a low dose of the stimulant amphetamine increased locomotor activity in wildtype mice but produced a paradoxical calming effect on locomotor activity in mTOR-cKO mice. In addition, mTOR-cKO mice exhibited impulsive behavior and attention deficits. Although mTOR-cKO mice share a striking resemblance to the distinct behavioral endophenotypes of hyperactivity, impulsivity, and inattention, this proposal does not seek to create a mouse model of a human neurodevelopmental illness. Instead, the long-term goal of this application is to investigate cellular and circuit mechanisms underlying the hyperactive and impulsive behavioral phenotypes. Three Specific Aims are proposed. In Aim I, we will examine how mTOR-cKO alters dopamine neuron physiology. In Aim II, we will investigate the mechanisms that underlie differential locomotor responses to amphetamine between the two genotypes. In Aim III, we will investigate the molecular and circuit mechanisms underlying impulsive behavior and attention deficits in mTOR-cKO mice. Together, these studies will elucidate mechanisms that govern hyperactive and impulsive behavior and provide novel insight into the role of mTOR signaling in regulating the function of dopamine neurons.
Grant Summary
The role of midbrain mTOR signaling in hyperactivity and impulsivity is a NIMH - National Institute of Mental Health grant providing up to $521K for university, nonprofit, healthcare org. Applications are due 2031-01-31 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $521K
2031-01-31
- 1Confirm your organization is eligible for The role of midbrain mTOR signaling in hyperactivity and impulsivity from NIMH - National Institute of Mental Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIMH - National Institute of Mental Health before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIMH - National Institute of Mental Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
The role of midbrain mTOR signaling in hyperactivity and impulsivity: Frequently Asked Questions
Who is eligible for the The role of midbrain mTOR signaling in hyperactivity and impulsivity?
The role of midbrain mTOR signaling in hyperactivity and impulsivity is offered by NIMH - National Institute of Mental Health and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the The role of midbrain mTOR signaling in hyperactivity and impulsivity provide?
The role of midbrain mTOR signaling in hyperactivity and impulsivity provides up to $521K per award from NIMH - National Institute of Mental Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the The role of midbrain mTOR signaling in hyperactivity and impulsivity deadline?
Applications for The role of midbrain mTOR signaling in hyperactivity and impulsivity are due 2031-01-31 (open). Because deadlines can change, verify the date with the funder, NIMH - National Institute of Mental Health, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the The role of midbrain mTOR signaling in hyperactivity and impulsivity?
To apply for The role of midbrain mTOR signaling in hyperactivity and impulsivity, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIMH - National Institute of Mental Health.